HomeCompareCRKT vs MRK

CRKT vs MRK: Dividend Comparison 2026

CRKT yields 5714.29% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRKT wins by $228153224412509.53M in total portfolio value
10 years
CRKT
CRKT
● Live price
5714.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$228153224412509.59M
Annual income
$220,560,399,839,122,060,000.00
Full CRKT calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CRKT vs MRK

📍 CRKT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRKTMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRKT + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRKT pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRKT
Annual income on $10K today (after 15% tax)
$485,714.29/yr
After 10yr DRIP, annual income (after tax)
$187,476,339,863,253,750,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CRKT beats the other by $187,476,339,863,253,750,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRKT + MRK for your $10,000?

CRKT: 50%MRK: 50%
100% MRK50/50100% CRKT
Portfolio after 10yr
$114076612206254.83M
Annual income
$110,280,199,919,561,030,000.00/yr
Blended yield
96.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CRKT
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRKT buys
0
MRK buys
0
No recent congressional trades found for CRKT or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRKTMRK
Forward yield5714.29%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$228153224412509.59M$56.8K
Annual income after 10y$220,560,399,839,122,060,000.00$9,798.13
Total dividends collected$227641622319776.13M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CRKT vs MRK ($10,000, DRIP)

YearCRKT PortfolioCRKT Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$582,129$571,428.57$11,206$366.19+$570.9KCRKT
2$31,711,186$31,088,308.22$12,650$502.35+$31.70MCRKT
3$1,616,661,128$1,582,730,159.44$14,407$694.19+$1616.65MCRKT
4$77,139,944,357$75,410,116,950.20$16,585$967.82+$77139.93MCRKT
5$3,445,379,409,484$3,362,839,669,021.90$19,342$1,363.89+$3445379.39MCRKT
6$144,058,436,084,716$140,371,880,116,567.28$22,913$1,947.19+$144058436.06MCRKT
7$5,639,412,164,337,400$5,485,269,637,726,755.00$27,662$2,823.89+$5639412164.31MCRKT
8$206,716,597,857,094,600$200,682,426,841,253,570.00$34,159$4,173.35+$206716597857.06MCRKT
9$7,096,097,732,137,874,000$6,874,910,972,430,782,000.00$43,337$6,308.80+$7096097732137.83MCRKT
10$228,153,224,412,509,600,000$220,560,399,839,122,060,000.00$56,776$9,798.13+$228153224412509.53MCRKT

CRKT vs MRK: Complete Analysis 2026

CRKTStock

Cirmaker Technology Corporation engages in the manufacture, distribution, and assembling of various electronic parts and components for sale primarily in the Asian markets. It provides electronic terminals, electronic blocks and accessories, electronic panel control and locking components, power distribution blocks and accessories, electronic timer and relay sockets, optical fiber connectors and adapters, car audio components, DVD players, electronics, cooling fins and systems for laptop and personal computers, and electrical tools, and other devices. The company also manufactures LCD backlight components and produces voice over Internet Protocol telephones. Further, it distributes or resells crimping tools, switches, cable ties, meters, sirens, power cords, and terminal strips, as well as imports and exports computer chips and various electronic products. Cirmaker Technology Corporation sells its products through sales personnel and marketing agents. The company was organized in 1984 and is based in Taoyuan, Taiwan.

Full CRKT Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CRKT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRKT vs SCHDCRKT vs JEPICRKT vs OCRKT vs KOCRKT vs MAINCRKT vs JNJCRKT vs ABBVCRKT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.